{
    "2019-03-04": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Here's Why Voyager Therapeutics Stock Rose as Much as 13% Today",
                "features": {
                    "keywords": [
                        "Voyager Therapeutics",
                        "Stock Rose",
                        "13%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "Top Research Reports for Intel, AbbVie & United Technologies",
                "features": {
                    "keywords": [
                        "Intel",
                        "AbbVie",
                        "United Technologies",
                        "Research Reports"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "industrials"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-17",
                "original_text": "AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "CHMP Nod",
                        "Psoriasis",
                        "Risankizumab"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-18",
                "original_text": "This Is Why TG Therapeutics Stock Soared 65.9% in February",
                "features": {
                    "keywords": [
                        "TG Therapeutics",
                        "Stock Soared",
                        "65.9%",
                        "February"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}